Cytology and Biomarkers in NMIBC
Cystoscopy and cytology remain the standard for diagnosis, but a plethora of urinary biomarkers could someday be a useful adjunct to NMIBC surveillance.
Bladder Cancer
FEATURES
Latest Bladder Cancer News
Bladder Cancer Linked to Early Menopause in Smokers
Among women with a history of smoking, menopause onset at age 45 or younger is associated with a 66% higher risk of bladder cancer compared with onset at age 50 or older.
Bladder Cancer Surgery Delay Increases Death Risk
Patients who undergo radical cystectomy for MIBC more than 12 weeks from diagnosis are at increased risk of death, regardless of whether they receive neoadjuvant chemotherapy.
Squamous MIBC Histology Predicts Worse Survival
Squamous cell carcinoma is associated with a 79% increased risk of death compared with urothelial carcinoma in patients with muscle-invasive bladder cancer, study finds.
Suicide Risk Up More Than 4-fold for Cancer Patients
Standardized mortality ratio highest for cancers of lung, head and neck, testes, bladder, Hodgkin lymphoma.
Global Demand for Bladder Cancer Treatment Threatens Supply in 2019
TICE BCG is indicated for the treatment and prophylaxis of carcinoma in situ of the urinary bladder and for the prophylaxis of primary or recurrent stage Ta and/or T1 papillary tumors following transurethral resection.
Smoking Associated With Worse Bladder Cancer Outcomes
Smokers had poorer response to cisplatin-based neoadjuvant chemotherapy, higher recurrence risk.
Post-Cystectomy Short-Term Complications Not Hiked by NAC
Researchers found no significant difference in 30-day postoperative complications between patients who received neoadjuvant chemotherapy and those who did not.
Neoadjuvant Chemotherapy for MIBC Ups Disease-Free Survival
Patients with muscle-invasive bladder cancer had a 22% decreased risk of disease progression if they received neoadjuvant rather than adjuvant chemotherapy, a study found.
Noninvasive Diagnostic Imaging Accurately IDs Bladder Cancer
Method evaluating cells collected from urine shows 94% diagnostic accuracy.
Post-Cystectomy Readmission Predictors Identified
Overweight and obesity, diabetes, and postoperative complications increase the likelihood of being readmitted within 30 days of hospital discharge among radical cystectomy patients.
Want to read more?
Please login or register first to view this content.
Next post in Bladder Cancer
